
News • Infectious Diseases
Abbott’s Testing Platform Iridica Now Available in Europe
Abbott announced its innovative diagnostic platform, known as Iridica, is now available in Europe and other CE–Mark recognized countries. The new platform can identify more than 1,000 infection–causing pathogens in less than six hours.